12th Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ
|
NCCIH, NCI, NHLBI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NINR
|
2014
|
|
2024-2028 NIH-Wide Strategic Plan on Research on the Health of Women
|
Other
|
AHRQ, CDC, FDA, HRSA, OASH
|
CC, CSR, NCATS, NCCIH, FIC, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ OEPR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ SGMRO
|
2022
|
|
3D Bioprinted skin models for drug screening
|
Research Initiative
|
FDA
|
NCATS
|
|
|
4th National Conference on Advancing Early Psychosis Care in the United States: Harnessing Resiliency in a Changing World
|
Meeting/ Workshop
|
SAMHSA
|
|
2018
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and prostate cancer
|
Research Initiative
|
CDC
|
|
2020
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
|
2019
|
|
A nested case-control study of serum PFAS and testicular cancer in Air Force servicemen
|
Research Initiative
|
CDC
|
|
2019
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
|
1998
|
|
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2011
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
A5418: Study of Tecovirimat For Human Monkeypox Virus (STOMP)
|
Other
|
CDC, FDA
|
NIAID
|
2022
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Therapeutics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-1: Immune Modulators (ACTIV-1)
|
Research Initiative
|
FDA, ASPR
|
NCATS
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-6: Outpatient Repurposed Drugs (ACTIV-6)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID, NHLBI, NCATS
|
2021
|
|
Accelerating Medicines Partnership (AMP)
|
Other
|
FDA
|
NIA, NIDDK, NIAMS, NINDS, NIMH
|
2014
|
|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
AccessGUDID
|
Resource Development
|
FDA, GDM
|
|
2015
|
|
ACL Advisory Council on Grandparents Raising Grandchildren
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, SAMHSA, CDC, HRSA, ASPE, ONC
|
|
2019
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
|
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA, ASPR
|
NCI, NIAID
|
2013
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
|
|
Adolescent Human Immunodeficiency Virus (HIV) Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
2016
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, IHS, OCR
|
NIEHS, NIDDK
|
2019
|
|
Advancing Protection and Care for Children in Adversity: A U.S. Government Strategy for International Assistance (APCCA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NICHD, NIMH
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2015
|
|
Advisory Committee on Immunization Practices (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
|
|
Advisory Committee on Maternal/Pediatric RSV Vaccines (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, HRSA, IHS, CMS
|
NIAID
|
2022
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Advisory Group, or Work Group
|
HRSA, OS
|
NIAID
|
2009
|
|
Advisory Committee on RSV Vaccines in Older Adults (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, CMS
|
|
2022
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
Agency Priority Goals Maternal Health
|
Committee, Advisory Group, or Work Group
|
HRSA, NIH, ASPE, CDC, CMS, FDA, OASH, ACF, OGA, AHRQ, ACL
|
OD/ DPCPSI/ ORWH, NICHD, OD/ IMOD, OD/ DPCPSI/ OEPR
|
2022
|
|
Alaska Native Tumor Registry
|
Resource Development
|
CDC, IHS
|
|
1999
|
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
Research Initiative
|
FDA
|
NIAAA
|
|
|
All of Us IAA with CDC Office of Public Health Genomics
|
Other
|
CDC
|
|
2021
|
|
Alzheimers.gov Collaborations with Federal Agencies
|
Public Education Campaign
|
ACL, ASPA, ASPE, CDC
|
NIA, NINDS
|
2020
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS (AAP-COPA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Council on Genetics (AAP-COG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Section on Obesity (AAP-SOO)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics Council on Injury, Violence and Poison Prevention (AAP-COIVPP)
|
Committee, Advisory Group, or Work Group
|
ACF, HRSA, IHS
|
NICHD
|
2011
|
|
American Community Survey (ACS) Interagency Committee Meeting
|
Meeting/ Workshop
|
ACF, AHRQ, ASPE, CDC, CMS, HRSA
|
NICHD
|
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
Americas Children Forum on Health and Family Statistics
|
Resource Development
|
SAMHSA
|
NIDA
|
1994
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NCATS, NHLBI, NIMH, NINDS
|
2019
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Analytical Methods and Reference Materials Program (AMRM)
|
Resource Development
|
FDA
|
NCCIH, NCI, NIDDK
|
2002
|
|
Ancillary Swab Study to PREVENT-19 trial: Swab your Nose Inside to Find inFection (SNIFF)
|
Research Initiative
|
ASPR, CDC, FDA
|
|
2021
|
|
Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ, CDC
|
FIC, NHGRI, NHLBI, NIAAA, NIDA, NIDDK, NIMH, NIMHD, NINR, NIEHS, OD
|
2014
|
|
Antibody Interest Group (ABIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NIAID, NIDCR, NIDDK
|
2010
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC
|
NICHD
|
1989
|
|
Antiviral Program for Pandemics
|
Research Initiative
|
ASPR
|
NIAID, NCATS, OD/ DPCPSI/ ORIP
|
2020
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Assay subgroup for SARS-CoV-2
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, BARDA, FDA
|
NIAID
|
2020
|
|
Assessing the Burden of Diabetes by Type in Children, Adolescents, and Young Adults Network (DiCAYA)
|
Resource Development
|
CDC
|
|
2020
|
|
Assessment of Inhalation Exposures to Indoor and Occupational Aerosols
|
Research Initiative
|
CDC
|
NIEHS
|
2014
|
|
Assessment of task-based exposures that may affect reproductive health in nail salon employees
|
Research Initiative
|
CDC
|
|
2021
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Bacteriophage Interest Group (BIG)
|
Other
|
FDA
|
NIAID
|
|
|
BARDA-DRIVe (DRIVE)
|
Research Initiative
|
ASPR
|
NIAID
|
2022
|
|
Behavioral Health Coordinating Council (BHCC) Children and Youth Behavioral Health Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CMS, ACL, AHRQ, FDA, IHS, ASPE, CDC, OASH
|
NICHD, NIMH, NIDA
|
2021
|
|
Behavioral Health Coordinating Council (BHCC) Performance Measures, Data, and Evaluation Subcommittee (MDE)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIMH
|
2021
|
|
Bench to Bedside: Integrating Sex and Gender to Improve Human Health
|
Resource Development
|
FDA
|
|
2017
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NICHD
|
2009
|
|
Best Pharmaceuticals for Children Act (BPCA) Research Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NHLBI, NCI
|
|
|
Best Pharmaceuticals for Children Act (BPCA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NHLBI, NCI
|
|
|
Biodefense Coordination Team (BCT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
2019
|
|
Biodosimetry Trans-NIH Working Group and Special Journal Issue
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
|
2019
|
|
Biomarkers of Exposure and Effect in Agriculture (BEEA)
|
Research Initiative
|
CDC
|
|
2018
|
|
Biomarkers of Exposure and Effect in Agriculture (Water Contaminants)
|
Research Initiative
|
CDC
|
|
2019
|
|
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
|
Research Initiative
|
FDA
|
NIBIB
|
|
|
Blood Products Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2011
|
|
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CC, NIAID7, NHLBI
|
2012
|
|
Board of Scientific Counselors (BSC) of the CDC National Center for Injury Prevention and Control
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIA, NICHD, NIDA, NIMH
|
2011
|
|
Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
Botanical Safety Consortium
|
Research Initiative
|
FDA
|
NCCIH
|
2019
|
|
Botulism Guidelines Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2016
|
|
Brain Attack Coalition (BAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NINDS
|
1997
|
|
Brain Research through Advancing Innovative Neurotechnologies Initiative (BRAIN Initiative)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NEI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2014
|
|
BRIDG Standard Development
|
Research Initiative
|
FDA
|
|
2004
|
|
Bridge to Artificial Intelligence (Bridge2AI)
|
Research Initiative
|
FDA
|
NLM, NEI, NHGRI, NCCIH, NIBIB, NICHD, NCATS, NIMH, NIMHD, NIAID, NCI, NIAMS, NINDS, NIDA, NIA, NIGMS, FIC, OD/ DPCPSI/ OBSSR, OD/ AoU, OD/ DPCPSI/ ODSS
|
2021
|
|
Build UP Trust Challenge Prize
|
Resource Development
|
CDC, HRSA, OASH
|
NIMHD, NCI, NIA, NIAID, NIEHS, NINDS, NCATS, NIAMS, NIBIB, NIDA, NICHD
|
2021
|
|
Canadian - U.S. Dietary Reference Intakes Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NIDDK, OD/ DPCPSI/ ODS
|
2005
|
|
Cancer Diagnostic Devices Interagency Task Force (CD2) - MOU among NCI, FDA, HRSA
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
|
2021
|
|
Cancer Moonshot Award
|
Research Initiative
|
OS
|
NCI, NIDCD
|
2019
|
|
CCDI Molecular Target Platform
|
Resource Development
|
FDA
|
|
2021
|
|
CCR Vaccine Branch FACS Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CCR, LGI, Flow Cytometry Core
|
Research Initiative
|
FDA
|
NCI
|
|
|
CDC Acute Flaccid Myelitis Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NINDS
|
2018
|
|
CDC Integration with GrantSolutions
|
Resource Development
|
ACF, CDC
|
OD/ OER
|
2016
|
|
CDC Office of Public Health Genomics
|
Public Education Campaign
|
CDC
|
NHLBI
|
2017
|
|
CDC Pathogen Genomic Centers of Excellence (PGCoE)
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
2008
|
|
CDC/NIH Quarterly Check-ins
|
Other
|
CDC
|
NIMH, NIAID
|
2021
|
|
Cell-Surface Interactions in Pathogenesis
|
Research Initiative
|
FDA
|
NIDCR
|
|
|
Center for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) Opioids Work Group (OWG)
|
Committee, Advisory Group, or Work Group
|
CMS
|
NIDA, NCCIH, NINDS, NIMH
|
2018
|
|
Central Brain Tumor Registry of the United States (CBTRUS)
|
Research Initiative
|
CDC
|
|
2021
|
|
Cervical screening guidelines
|
Resource Development
|
CDC, HRSA, FDA
|
|
2019
|
|
CFAR Diversity, Equity, Inclusion Pipeline Initiative (CDEIPI)
|
Research Initiative
|
OASH
|
NIAID, NIMH, NCI, NHLBI, NIDDK, NINR, NIDCR, NIMHD, NICHD, NIA, FIC, OD/ DPCPSI/ OAR
|
2021
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
Chemical Hazards Emergency Medical Management (CHEMM) Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC
|
NLM, NICHD
|
2010
|
|
Chronic Kidney Disease Surveillance System
|
Health Survey
|
CDC
|
NIDDK
|
2006
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
|
2018
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical and Translational Serology Task Force (CTTF)
|
Resource Development
|
CDC, FDA, ASPR
|
NIAID
|
2021
|
|
Clinical Genome Resource and Genetic Testing Reference Material Program Collaborative Project (ClinGen and GeT-RM Collaborative Project)
|
Resource Development
|
CDC
|
|
2021
|
|
Clinical Immunization Safety Assessment Network (CISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NHLBI
|
2021
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Pharmacology Quality Assurance Program (CPQA)
|
Other
|
CDC
|
NIAID
|
2021
|
|
Clinical Research Using Medicare Data from the Virtual Research Data Center (VRDC)
|
Research Initiative
|
CMS
|
NLM
|
2016
|
|
Clinical Trials of Biodefense Vaccines (Dengue)
|
Research Initiative
|
CDC
|
NIAID
|
|
|
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2013
|
|
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records
|
Resource Development
|
CDC, CMS, FDA, ONC
|
NLM
|
2008
|
|
CMS MCBS, Dietary Supplements, Measures of Malnutrition and Frailty
|
Health Survey
|
CMS
|
|
2019
|
|
CMS-NIH Leadership Council
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIDA, NIDDK, NIMHD, OD/ IMOD, OD/ OER, OD/ OSP
|
2011
|
|
CMS/NIH/NHLBI Sickle Cell Disease Working Group
|
Meeting/ Workshop
|
CMS
|
|
2021
|
|
Collaborative Acute Toxicity Modeling Suite (CATMoS)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NCATS
|
2018
|
|
Collaborative on Healthy Parenting in Primary Care
|
Public Education Campaign
|
CDC, HRSA, SAMHSA
|
NICHD
|
|
|
Combating Antibiotic Resistant Bacteria (CARB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NIAID
|
2015
|
|
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee (CARBx-JOC)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC
|
NIAID
|
2016
|
|
Combined Exposures and Mixtures Research Program
|
Research Initiative
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
|
|
Commissioned Corps of the U.S. Public Health Service (USPHS) Oral Health Coordinating Committee (OHCC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, OASH, IHS, SAMHSA
|
|
1990
|
|
Community Guide Cardiovascular Coordination Team
|
Committee, Advisory Group, or Work Group
|
CDC
|
NHLBI
|
2013
|
|
Community Preventive Services Task Force (CPSTF)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, AHRQ, OASH, HRSA, IHS, SAMHSA
|
OD/ DPCPSI
|
1996
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC, OD/ OIR
|
2004
|
|
Congenital Heart Public Health Consortium
|
Resource Development
|
AHRQ, CDC
|
NHLBI
|
2008
|
|
Consumer Product Chemical Exposures in Pregnancy and Their Cumulative Impact on Disorders of Fetal Growth
|
Research Initiative
|
CDC
|
|
2020
|
|
Contract to fund Congressional mandated National Academies of Sciences, Engineering, and Medicine (NASEM) study on Organ Donation and Transplantation
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NHLBI, NIAID, NIDDK
|
2019
|
|
Coordinating Committee on Research on Women's Health (CCRWH) Sex, Gender, and Intersectionality (SG&I) Innovations Working Group (CCRWH SG&I Innovations WG)
|
Research Initiative
|
FDA, AHRQ, Other
|
OD, NIA, NHLBI, OD/ AoU, NIGMS, NICHD, NCI, NINDS, NIBIB, NCCIH, NIDA
|
2022
|
|
COPD National Action Plan
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, HRSA, IHS
|
NCI, NHLBI, NIA, NIEHS, NINR
|
2017
|
|
Countering Biothreats IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countering Biothreats sub-IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countermeasures Against Chemical Threats program (CounterACT)
|
Research Initiative
|
ASPR
|
NIAID, NIAMS, NICHD, NEI, NINDS, NIDA
|
2006
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya
|
Research Initiative
|
CDC
|
FIC, NIAID
|
2013
|
|
COVID antibody testing
|
Research Initiative
|
ASPR
|
NIAID
|
2020
|
|
Covid Serology Research and Results Tracker (SeroHub)
|
Resource Development
|
CDC
|
NIAID
|
2020
|
|
COVID-19 and Influenza Scenario Modeling Hubs (SMH)
|
Research Initiative
|
CDC
|
NIGMS
|
2020
|
|
COVID-19 Health and Safety Briefs
|
Training Initiative
|
CDC
|
|
2021
|
|
COVID-19 OpenData Portal
|
Research Initiative
|
ASPR
|
NCATS, NIAID, NLM
|
2020
|
|
COVID-19 Therapeutics Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIAID
|
2020
|
|
Critical Path for Rare Neurodegenerative Diseases (CP-RND)
|
Research Initiative
|
FDA
|
|
2022
|
|
CTAC Ad hoc Strategic Planning Working Group (CTAC SPWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS
|
|
2019
|
|
CTAC ad hoc Working Group on Streamlining Clinical Trials (CTAC SCTWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2022
|
|
CURE ID
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
CURE ID App for Infectious Disease Case Reporting
|
Research Initiative
|
FDA
|
NCI
|
|
|
Cytokine Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDCD
|
2007
|
|
DailyMed
|
Resource Development
|
FDA
|
|
2005
|
|
Data Access for Grantees
|
Resource Development
|
CMS
|
NIA
|
2010
|
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2012
|
|
Department of Health and Human Services (DHHS) Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, OD/ DPCPSI/ OAR
|
1989
|
|
Department of Health and Human Services (DHHS) Health Care Personnel Influenza Vaccination Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2008
|
|
Department of Health and Human Services (DHHS) Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2005
|
|
Department of Health and Human Services (DHHS) Medical Claims Review Panel
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
|
1990
|
|
Department of Health and Human Services (DHHS) Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2008
|
|
Department of Health and Human Services (HHS) Biovigilance Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2009
|
|
Department of Health and Human Services AAPI Memorandum Workgroup
|
Meeting/ Workshop
|
AHRQ, FDA, OASH, CDC, ASFR, ASPE, CMS
|
|
2021
|
|
Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing -SBIR/STTR Town Hall Meeting
|
Meeting/ Workshop
|
FDA
|
|
2020
|
|
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Development testing of nucleic acid-based vaccine for HIV other indications
|
Research Initiative
|
FDA
|
NCI
|
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OASH
|
NIDDK
|
1974
|
|
Diabetes Prevention Program Outcomes Study (DPP/DPPOS)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NIA
|
1994
|
|
Diabetic Eye Disease Information Dissemination
|
Public Education Campaign
|
CDC
|
NEI
|
2015
|
|
Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population
|
Research Initiative
|
CMS
|
|
2011
|
|
Diagnostics and Disease Management Tools for Use in Underserved Populations: An NHLBI Research & Implementation Workshop
|
Meeting/ Workshop
|
AHRQ, CMS, CDC, FDA, OASH, HRSA, IHS
|
NCATS, NIMHD, NIBIB
|
2021
|
|
Diet Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
|
2004
|
|
Dietary Supplement Label Database (DSLD)
|
Resource Development
|
FDA, CDC
|
NLM, OD/ DPCPSI/ ODSS, NCCIH, NCI
|
2004
|
|
Dietary Supplement Relevant - Special Interest Databases (purines, nitrates/nitrates)
|
Resource Development
|
FDA
|
|
2016
|
|
Dietary Supplement Research Coordination Committee (DSRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ONR
|
2022
|
|
Digestive Diseases Interagency Coordinating Committee (DDICC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NCI, NIBIB
|
1985
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
|
2011
|
|
Drug Development Interest Group
|
Committee, Advisory Group, or Work Group
|
ASPR
|
FIC, NCI, NHLBI, NIAID
|
2015
|
|
Drug Induced Liver Injury Network (DILIN)
|
Resource Development
|
FDA
|
NCI, NIDDK
|
2003
|
|
EAGeR Trial - The Effects of Aspirin in Gestation and Reproduction Trial
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC, HRSA
|
NIDCD
|
2007
|
|
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite with Coordinating Center
|
Research Initiative
|
HRSA
|
NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2019
|
|
Ebola Clinical Research Response in Democratic Republic of the Congo
|
Research Initiative
|
CDC, ASPR
|
NIAID
|
2018
|
|
Ebola Clinical Research Response in West Africa (Guinea, Liberia)
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
Ebola Vaccines Advisory Committee on Immunization Practices (ACIP) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
ECHO Institute and Project ECHO for Cancer Research and Control
|
Other
|
CDC
|
|
2017
|
|
Effective Data Management Subgroup of the Open Science Infrastructure Working Group of the Subcommittee on Open Science of the National Science and Technology Council Subcommittee on Open Science (NSTC OSTP SOS-EDM)
|
Committee, Advisory Group, or Work Group
|
ACL, ASPR, CDC
|
OD/ OSP
|
2019
|
|
EHE Operations Leadership Team (OLT)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, HRSA, IHS, SAMHSA, CMS
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
Emergency Preparedness, Medical Countermeasures (ASPR)
|
Resource Development
|
ASPR, CDC
|
|
2007
|
|
Emerging Contaminants and Issues of Concern Research Program
|
Research Initiative
|
CDC
|
NIEHS
|
|
|
Emerging Tobacco Products Communication Initiative Subject Matter Expert Work Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
End-stage Renal Disease Collaboration
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIBIB, NIDDK
|
2016
|
|
Ending the HIV Epidemic in the US administrative supplement announcement for NIH Centers for AIDS Research and NIMH AIDS Research Centers
|
Research Initiative
|
CDC, HRSA, Other
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NICHD
|
2003
|
|
Enhanced Federal Collaborations in Implementation Science and Research of HIV Prevention and Treatment
|
Other
|
CDC, HRSA
|
NIAID, NIMH
|
2022
|
|
Enhancing Scientific Collaboration between US and Colombia
|
Committee, Advisory Group, or Work Group
|
OGA
|
NIAID, FIC
|
2021
|
|
Environmental Phthalate Exposures In Pregnancy in Relation to Fetal and Placental Development
|
Research Initiative
|
CDC
|
|
2020
|
|
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
eRA Federal Shared Services (eRA)
|
Resource Development
|
AHRQ, FDA, SAMHSA, ASFR
|
OD/ OER
|
2016
|
|
Establishment of representative examination and dose repository for patients undergoing interventional fluoroscopic procedures
|
Research Initiative
|
FDA
|
|
2021
|
|
Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO RGN)
|
Research Initiative
|
HRSA
|
NHGRI
|
2021
|
|
Evaluation of Oropharyngeal responses to SARS-CoV-2
|
Research Initiative
|
FDA
|
NIAID
|
2020
|
|
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
Evaluation of Visual Function in Animal Models
|
Research Initiative
|
FDA
|
NEI
|
|
|
Evidence-Based Cancer Control Programs (EBCCP)
|
Resource Development
|
CDC
|
|
2003
|
|
Extracorporeal CPR (ECPR) for Out-of-hospital Cardiac Arrest
|
Meeting/ Workshop
|
OASH
|
|
2021
|
|
Factor VIII Inhibitors: Generating a National Blueprint for Future Research
|
Meeting/ Workshop
|
CDC
|
NCI, NHLBI, NICHD, NLM
|
2017
|
|
FDA Antimicrobial Drugs Advisory Committee (FDA AMDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2021
|
|
FDA CDER & NIH NCATS Regulatory Fitness in Rare Disease Clinical Trials Workshop
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2022
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
|
2020
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA-NCI Quarterly Meeting
|
Meeting/ Workshop
|
FDA
|
|
1991
|
|
FDA-NIH Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/ IMOD, OD/ OER, OD/ OSP
|
2010
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
Feasibility Study: Maternal Health Care of Pregnant Women in Custody, Expert Panel
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NICHD
|
|
|
Federal Cannabis Partners
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NIDA, NCI
|
|
|
Federal Cervical Cancer Collaboration
|
Resource Development
|
HRSA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
Federal Data Consortium on Pregnancy and Birth to 24 Months
|
Resource Development
|
CDC, FDA, OASH
|
NCATS, NCI, NHLBI, NIAID, NICHD, NIDDK, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ ORWH, OD/ ECHO
|
2016
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH, ACL
|
NHLBI, NIDDK
|
2005
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2010
|
|
Federal Health IT Coordinating Council
|
Committee, Advisory Group, or Work Group
|
CMS, ACF, AHRQ, CDC, FDA, HRSA, IHS, OASH, ASA
|
NHGRI, OD/ OSP
|
2004
|
|
Federal HIV Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2018
|
|
Federal HIV Web Council (HIV.gov) (FHWC)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, FDA, HRSA, IHS, SAMHSA, ACF
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Hypertension Control Leadership Council
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, ASPR, ONC
|
NHLBI, NINDS
|
2020
|
|
Federal Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NIAID, NIMH, NIDA, OD/ DPCPSI/ OAR
|
2018
|
|
Federal Interagency Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2009
|
|
Federal Interagency Forum for Child and Family Statistics
|
Research Initiative
|
ACF, AHRQ, CDC, HRSA, OS, SAMHSA
|
NICHD, NIMH
|
2010
|
|
Federal Interagency Forum on Aging Related Statistics
|
Resource Development
|
ACL, AHRQ, CDC, CMS, OS, SAMHSA
|
NIA
|
1986
|
|
Federal Interagency Task Force on the Arts and Human Development
|
Research Initiative
|
ACF, ACL, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
Federal Interagency Traumatic Brain Injury Research Working Group (FITBIR Working Group)
|
Resource Development
|
AHRQ, CDC, HRSA, OS, SAMHSA
|
CIT, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIGMS, NIMH, NINDS
|
2008
|
|
Federal Interagency Workgroup on Autism Spectrum Disorders (FIWA)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA, ASPE, ACF, FDA
|
NINDS, NICHD
|
2018
|
|
Federal Interagency Workgroup on Child Abuse and Neglect (FEDIAWG)
|
Committee, Advisory Group, or Work Group
|
ACF
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
1998
|
|
Federal Interagency Workgroup on Improving Diagnostic Safety and Quality in Health Care
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, ONC, SAMHSA, OASH, CMS
|
NIBIB, NLM, NCI, NCATS
|
2018
|
|
Federal Interagency Workgroup on Intellectual Disabilities/Developmental Disabilities (ID/DD) Administrative Data (FIW IAD)
|
Committee, Advisory Group, or Work Group
|
ACL, CMS, ASPE, CDC, HRSA, AHRQ, SAMHSA
|
NICHD, NIMH
|
2020
|
|
Federal Interagency Workgroup on Teen Dating Violence
|
Committee, Advisory Group, or Work Group
|
ACF, CDC
|
NICHD
|
2006
|
|
Federal Interagency Working Group on Measuring Sexual Orientation and Gender Identity (FIW SOGI)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CMS, SAMHSA
|
NICHD, OD/ DPCPSI/ SGMRO
|
2015
|
|
Federal Interagency Workshop: Nonhuman Primate Resources and Needs for Biomedical Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ DPCPSI/ OAR, OD/ OIR, OD/ ORS, OD/ OSP, CC, NCCIH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIMH, NINDS
|
2021
|
|
Federal Lead Action Plan Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
|
|
|
Federal Partners in Bullying Prevention, Intervention, and Recovery
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
2010
|
|
Federal Sudden Unexpected Infant Death/Sudden Infant Death Syndrome (SUID/SIDS) Workgroup
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS
|
NICHD
|
2009
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Tuberculosis (TB) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
Federal Work Group on Suicide Prevention
|
Committee, Advisory Group, or Work Group
|
SAMHSA, CDC, IHS, ACF, ACL, AHRQ, HRSA, ASPE
|
NIDA, NIMH, NIAAA
|
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
CSR, NCATS, NCI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ORWH, NIAAA
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ ORWH
|
2005
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG) Workshop
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
FNIH Advanced Medicines Partnership® - Bespoke Gene Therapy Consortium (FNIH AMP BGTC)
|
Research Initiative
|
FDA
|
NCATS
|
2019
|
|
FNIH Biomarkers Consortium (FNIH)
|
Research Initiative
|
CMS, FDA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS
|
2006
|
|
Focus on Aging: Federal Partners Webinar Series
|
Public Education Campaign
|
ACL, CDC, HRSA
|
NIA
|
2017
|
|
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Foundation for the National Institutes of Health (FNIH) PACT (Partnership for Accelerating Cancer Therapies) (FNIH PACT)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2017
|
|
Full-text health-related documents at NLM (includes HSTAT) Bookshelf/Digital Repository
|
Resource Development
|
AHRQ, ATSDR, CDC, CMS, FDA, SAMHSA
|
|
1994
|
|
Functional and Structural Optical Brain Imaging
|
Research Initiative
|
FDA
|
NICHD
|
|
|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF, ACL, AHRQ, CDC, CMS, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ DPCPSI/ THRO, OD/ DPCPSI/ SGMRO, OD/ ECHO, OD/ IMOD, OD/ OCPL, OD/ OER, OD/ OIR, OD/ OIR/ OTT, OD/ OLPA, OD/ OM/ OB, OD/ ORS, OD/ OSP
|
2016
|
|
FY 22 Ending the HIV Epidemic in the US Funding Opportunity Announcement
|
Research Initiative
|
CDC, HRSA
|
NIAID, NIMH, NIDA
|
2022
|
|
Gabriella Miller Kids First Common Fund Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/ DPCPSI/ ORIP
|
2015
|
|
Gender Policy Council: HHS Women's Health & Rights Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, HRSA, CDC, OGA, OASH
|
NICHD
|
|
|
Genetic Epidemiology of Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
|
|
Genetic Epidemiology of Diabetic Complications
|
Research Initiative
|
IHS
|
|
|
|
Genetic Studies in the National Birth Defects Prevention Study (NBDPS)
|
Research Initiative
|
CDC
|
NHGRI
|
2014
|
|
Genital Herpes Workshop
|
Meeting/ Workshop
|
CDC
|
NIAID
|
2022
|
|
Genome in a Bottle Consortium (GIAB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NCI
|
2013
|
|
Genomic epidemiology of norovirus GII.4 globally
|
Research Initiative
|
FDA
|
|
2022
|
|
Global Burden of Disease U.S. Health Disparities Working Group
|
Resource Development
|
CDC
|
NHLBI, NCI, NIA, OD/ DPCPSI/ OBSSR, NIAMS
|
|
|
Global Environmental and Occupational Health (GEOHealth)
|
Research Initiative
|
CDC
|
FIC, NCI, NIEHS, OD/ DPCPSI/ ORWH
|
2011
|
|
Global Health Security Agenda (GHSA) Action Package Prevent 3 (APP3), Biosafety and Biosecurity Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2014
|
|
Global Initiative for Cancer Registry Development (GICR)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2014
|
|
Global Nutrition Coordination Plan (GNCP)
|
Committee, Advisory Group, or Work Group
|
CDC, OGA, FDA
|
NICHD, NCI
|
2016
|
|
Global Substance Registration System (GSRS)
|
Research Initiative
|
FDA
|
NCATS, OD/ OIR
|
2013
|
|
GlycoBiology Scientific Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Government-University-Industry Research Roundtable (GUIRR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ IMOD, NCATS
|
|
|
H-CORE
|
Committee, Advisory Group, or Work Group
|
ASPR/BARDA
|
NIAID
|
2022
|
|
Harmonization of Various Common Data Models and Open Standards for Evidence Generation (CDMH II)
|
Resource Development
|
FDA
|
NCATS, NCI, NLM
|
2016
|
|
HDPulse Dissemination and Adaptation Working Group
|
Resource Development
|
OASH
|
|
|
|
Health and Retirement Study (HRS)
|
Research Initiative
|
CDC, CMS
|
NIA
|
1992
|
|
Health Information Technology Advisory Committee (HITAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, ONC
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS
|
2014
|
|
Health Promotion Activity to Recognize National Minority Health Month
|
Public Education Campaign
|
OASH
|
NIMHD
|
2022
|
|
Healthy People 2020/2030 Heart Disease and Stroke Federal Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NHLBI, NINDS
|
2010
|
|
Healthy People 2030 - Chronic Kidney Disease Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS, OASH
|
|
1998
|
|
Healthy People 2030 - Heart Disease and Stroke Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS
|
NHLBI, NINDS
|
2000
|
|
Healthy People 2030 - Nutrition and Weight Status Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, Other
|
NIDDK
|
2010
|
|
Healthy People 2030 - Respiratory Diseases
|
Health Survey
|
CDC
|
NHLBI, NIA, NICHD, NIDA, NIDDK, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS
|
2000
|
|
Healthy People 2030 - Sleep Health
|
Health Survey
|
CDC
|
NHLBI, NIA, NICHD, NIDA, NIDDK, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS
|
2000
|
|
Healthy People 2030 - Social Determinants Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, OASH, SAMHSA, PSC, FDA
|
NIA, NCI, NIAAA, NIMHD
|
2016
|
|
Healthy People 2030 Chronic Pain Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, OASH
|
|
2020
|
|
Healthy People 2030 Disability and Health Work Group
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD
|
|
|
Healthy People Initiative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDCD, NIDDK, NIEHS, NIMH, NINDS
|
1979
|
|
Healthy People Initiative - Visual Health
|
Health Survey
|
AHRQ, CDC
|
NEI
|
2011
|
|
Healthy Vision Month
|
Public Education Campaign
|
CDC
|
NEI
|
2014
|
|
Heart Failure Collaboratory
|
Meeting/ Workshop
|
CMS, FDA
|
|
2017
|
|
Heart Valve Collaboratory
|
Meeting/ Workshop
|
CMS, FDA
|
|
2020
|
|
Helicobacter pylori Genome Project (HpGP)
|
Research Initiative
|
CDC
|
NLM
|
2016
|
|
Hepatitis B Research Network (HBRN)
|
Research Initiative
|
CDC
|
NCI, NIDDK
|
2008
|
|
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK, NIMHD
|
2011
|
|
HHS Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
HHS Adult Maltreatment Prevention Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
NIA
|
2018
|
|
HHS Agency Priority Goal on Equity Workgroup (FY 2022-2023)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, CDC, CMS, HRSA
|
OD/ OEDI, NICHD, NIMHD
|
2021
|
|
HHS Antiretroviral Treatment Guidelines Panel for Adults and Adolescents with HIV
|
Committee, Advisory Group, or Work Group
|
HRSA, CDC, FDA
|
NIAID
|
1996
|
|
HHS Behavioral Health Coordinating Council (BHCC) Overdose Prevention Subcommittee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA, OASH, ASPE
|
NIDA, OD/ OSP
|
2009
|
|
HHS Behavioral Health Coordinating Council, Subcommittee on Children and Youth
|
Committee, Advisory Group, or Work Group
|
HRSA, SAMHSA, FDA, OASH, CMS
|
NICHD, NIMH, NIDA
|
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biosafety and Biosecurity Coordinating Council (HHS BBCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ ORS, OD/ OSP
|
2015
|
|
HHS Border Health Intra-agency Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, OS
|
NIA, NIAID, NICHD, NIDDK, NIMH, NIMHD
|
2008
|
|
HHS Coordination Operations and Response Element (previously Operation Warp Speed) (H-CORE/OWS)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
HHS DATA Act Compliance
|
Committee, Advisory Group, or Work Group
|
ASFR
|
OD/ OM/ NBS
|
2020
|
|
HHS Data Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASFR, ASPA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, ONC, OMHA
|
NLM, NIGMS, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ SGMRO
|
1996
|
|
HHS Data Governance Board
|
Committee, Advisory Group, or Work Group
|
OCIIO, ASPE, CDC, ACF, ACL, AHRQ, CMS, FDA, HRSA, IHS, SAMHSA, ASFR, ASPA, ASPR, OIG
|
OD/ OSP
|
2020
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OASH
|
NIDDK
|
1990
|
|
HHS Disability Collaborative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPA, ASPE, ASFR, ASA, ASPR, ACF, CDC, CMS, OASH, OCR, ONC, OIG, OGA, HRSA, SAMHSA, FDA, IHS
|
NIA, NICHD
|
2020
|
|
HHS Ebola Medical Countermeasures Scientific Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, OGA, CDC, FDA
|
|
2018
|
|
HHS Environmental Justice and Natural Disasters Working Group (EJ)
|
Committee, Advisory Group, or Work Group
|
ASPR, OASH, CDC, HRSA
|
NIEHS
|
2012
|
|
HHS Environmental Justice Working Group (EJWG)
|
Committee, Advisory Group, or Work Group
|
OASH
|
NIEHS, OD/ DPCPSI/ SGMRO
|
2022
|
|
HHS Health Disparities Council
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIMHD
|
|
|
HHS HIV Bidirectional Meeting Planning Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIMH
|
2018
|
|
HHS LGBT Policies Coordinating Committee (HHS LGBT CC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIMH, OD/ DPCPSI/ SGMRO
|
2011
|
|
HHS Liaison to NASA
|
Other
|
FDA
|
NCATS, OD/ IMOD
|
2018
|
|
HHS Long COVID Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, AHRQ
|
NIDA, NIMH
|
2022
|
|
HHS Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPE, ASFR, CDC, CMS, FDA, HRSA, IHS, ONC, IOS, ATSDR, SAMHSA
|
NICHD, OD/ DPCPSI/ ORWH, NHLBI
|
|
|
HHS Minority Health Offices Directors Committee
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, HRSA, IHS, FDA, SAMHSA
|
|
2020
|
|
HHS Noise-Induced Hearing Loss Federal Partner Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2018
|
|
HHS Nutrition Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, NIH, OASH, SAMHSA, OS
|
NHLBI, NCI, OD/ DPCPSI/ ORWH
|
2021
|
|
HHS Office on Womens Health, Section on Pregnancy and Newborn Care
|
Committee, Advisory Group, or Work Group
|
OS, SAMHSA
|
NICHD, NIMH
|
|
|
HHS Panel for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Potential Pandemic Pathogens Care and Oversight Review Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2018
|
|
HHS Privacy Committee
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OM
|
|
|
HHS Reproductive Health Care Access Task Force (HHS RATF)
|
Committee, Advisory Group, or Work Group
|
OASH, OCR, ASPE, AHRQ, CDC, HRSA, IHS
|
OD
|
2022
|
|
HHS SARS-CoV-2 Assay Development Task orders
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
HHS SARS-CoV-2 Immune Assay Testing of Ph3 clinical samples- Task Order
|
Resource Development
|
ASPR
|
NIAID
|
2020
|
| |